Home/OKYO Pharma/Robert Dempsey
RD

Robert Dempsey

Chief Executive Officer/Director

OKYO Pharma

OKYO Pharma Pipeline

DrugIndicationPhase
Urcosimod (OK-101)Neuropathic Corneal Pain (NCP)Phase 2